- Home
- FCF vs PRAX Comparison
FCF vs PRAX Comparison
Compare FCF & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCF
- PRAX
- Stock Information
- Founded
- FCF 1934
- PRAX 2015
- Country
- FCF United States
- PRAX United States
- Employees
- FCF N/A
- PRAX N/A
- Industry
- FCF Major Banks
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- FCF Finance
- PRAX Health Care
- Exchange
- FCF Nasdaq
- PRAX Nasdaq
- Market Cap
- FCF 1.7B
- PRAX 1.4B
- IPO Year
- FCF N/A
- PRAX 2020
- Fundamental
- Price
- FCF $16.91
- PRAX $83.49
- Analyst Decision
- FCF Buy
- PRAX Strong Buy
- Analyst Count
- FCF 7
- PRAX 9
- Target Price
- FCF $19.36
- PRAX $149.11
- AVG Volume (30 Days)
- FCF 712.6K
- PRAX 350.3K
- Earning Date
- FCF 01-28-2025
- PRAX 03-04-2025
- Dividend Yield
- FCF 3.11%
- PRAX N/A
- EPS Growth
- FCF N/A
- PRAX N/A
- EPS
- FCF 1.39
- PRAX N/A
- Revenue
- FCF $448,502,000.00
- PRAX $1,605,000.00
- Revenue This Year
- FCF N/A
- PRAX N/A
- Revenue Next Year
- FCF $6.29
- PRAX N/A
- P/E Ratio
- FCF $12.03
- PRAX N/A
- Revenue Growth
- FCF N/A
- PRAX N/A
- 52 Week Low
- FCF $12.41
- PRAX $33.01
- 52 Week High
- FCF $19.96
- PRAX $86.93
- Technical
- Relative Strength Index (RSI)
- FCF 52.15
- PRAX 62.96
- Support Level
- FCF $16.11
- PRAX $73.50
- Resistance Level
- FCF $16.80
- PRAX $83.24
- Average True Range (ATR)
- FCF 0.40
- PRAX 4.30
- MACD
- FCF 0.08
- PRAX 0.89
- Stochastic Oscillator
- FCF 74.78
- PRAX 94.95
About FCF First Commonwealth Financial Corporation
First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.